Dorzolamide Hydrochloride-Timolol Maleate (Lannett Company, Inc.)
Welcome to the PulseAid listing for the Dorzolamide Hydrochloride-Timolol Maleate drug offered from Lannett Company, Inc.. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lannett Company, Inc. |
| NON-PROPRIETARY NAME: | Dorzolamide Hydrochloride-Timolol Maleate |
| SUBSTANCE NAME: | DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-12-17 |
| END MARKETING DATE: | 0000-00-00 |
Dorzolamide Hydrochloride-Timolol Maleate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dorzolamide Hydrochloride-Timolol Maleate from Lannett Company, Inc. |
| LABELER NAME: | Lannett Company, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 5(mg/mL; mg/mL) |
| START MARKETING DATE: | 2014-12-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0527-1763_b981255a-fe82-4953-9f3c-04977df0d9d2 |
| PRODUCT NDC: | 0527-1763 |
| APPLICATION NUMBER: | ANDA201998 |
Other DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE Pharmaceutical Manufacturers / Labelers:
